Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial-Reference-Cited by-同舟云学术

Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial

Published:2018-07-13 Issue:10 Volume:73 Page:2860-2866
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Santolaya María E¹²,Alvarez Ana M²³,Acuña Mirta²⁴,Avilés Carmen L²⁵,Salgado Carmen²⁶,Tordecilla Juan²⁴,Varas Mónica²³,Venegas Marcela²⁵,Villarroel Milena¹²,Zubieta Marcela²⁶,Farfán Mauricio⁷,de la Maza Verónica¹,Vergara Alejandra⁷,Valenzuela Romina¹,Torres Juan P¹

Affiliation:

1. Department of Pediatrics, Hospital Dr. Luis Calvo Mackenna, Faculty of Medicine, Universidad de Chile, Santiago, Chile

2. Committee of Infectious Diseases, National Child Programme of Antineoplastic Drugs (PINDA), Santiago, Chile

3. Department of Pediatrics, Hospital San Juan de Dios, Faculty of Medicine, Universidad de Chile, Santiago, Chile

4. Department of Pediatrics, Hospital Dr. Roberto del Río, Faculty of Medicine, Universidad de Chile, Santiago, Chile

5. Department of Pediatrics, Hospital San Borja Arriarán, Faculty of Medicine, Universidad de Chile, Santiago, Chile

6. Department of Pediatrics, Hospital Dr. Exequiel González Cortés, Faculty of Medicine, Universidad de Chile, Santiago, Chile

7. Center for Molecular Studies, Hospital Dr. Luis Calvo Mackenna, Faculty of Medicine, Universidad de Chile, Santiago, Chile

Funder

National Fund for Scientific and Technological Development

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/10/2860/25770385/dky244.pdf

Reference30 articles.

1. Invasive fungal infections in pediatric oncology;Mor;Pediatr Blood Cancer,2011

2. Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species;Drgona;Eur J Clin Microbiol Infect Dis,2014

3. Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: a prospective, multicenter evaluation;Villarroel;Pediatr Infect Dis J,2010

4. Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review;Fisher;J Pediatric Infect Dis Soc,2017

5. Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006;Hahn-Ast;J Antimicrob Chemother,2010

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiological changes of invasive fungal disease in children with cancer: Prospective study of the National Child Program of Antineoplastic Drugs network, Chile;Mycoses;2024-08

2. An update on pharmacotherapy for fungal infections in allogeneic stem cell transplant recipients;Expert Opinion on Pharmacotherapy;2024-07-23

3. Systematic review on efficacy and safety of empirical versus pre‐emptive antifungal therapy among children with febrile neutropenia reveals paucity of data;Mycoses;2024-04

4. Clinical characteristics, epidemiology, and mortality of patients receiving antifungal therapy at a university hospital of the Triângulo Mineiro, Brazil;Revista de Epidemiologia e Controle de Infecção;2024-03-08

5. Safety and efficacy of pre-emptive antifungal therapy versus empirical therapy in patients with febrile neutropenia – A meta-analysis;Global Journal of Health Sciences and Research;2024-03-01